Ramsay Health Care Limited

As of June 30, 2025, Ramsay Health Care Limited carries a market capitalization of 4.75B, placing it among publicly traded companies globally. Its enterprise value stands at 11.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Ramsay Health Care Limited's next confirmed earnings release is scheduled for March 3, 2027.

As of June 30, 2025, Ramsay Health Care Limited has 230.80M shares outstanding.

As of June 30, 2025, Ramsay Health Care Limited trades at a trailing price-to-earnings ratio of 352.59. The price-to-sales ratio is 0.48, and the price-to-book ratio stands at 1.69.

As of June 30, 2025, Ramsay Health Care Limited trades at an EV/EBITDA multiple of 12.30 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.16 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 37.77 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 11.47B versus a market cap of 4.75B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2025, Ramsay Health Care Limited maintains a current ratio of 0.90, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 212.31, indicating elevated leverage, while an interest coverage ratio of 4.98 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2025, Ramsay Health Care Limited posted a return on equity (ROE) of 0.48, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 1.43 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 0.11, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 0.90, useful for judging operating efficiency across full business cycles. The company generates approximately 109,666.64 in revenue per employee across its workforce of 90,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 10.22 indicates how many times Ramsay Health Care Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2025, Ramsay Health Care Limited recorded 30.99M in income tax expense. That works out to an effective tax rate of 54.52, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 56.85M, leaving 13.40M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on September 2, 2026, Ramsay Health Care Limited's stock has gained approximately 69.63% over the past 52 weeks. The 50-day moving average sits at 27.16, while the 200-day moving average is 23.41.

Over the twelve months ended June 30, 2025, Ramsay Health Care Limited generated 9.87B in revenue and converted that into 13.40M in net income, yielding earnings per share of 0.11. EBITDA reached 932.55M, while operating income came in at 486.13M.

As of June 30, 2025, Ramsay Health Care Limited holds 438.04M in cash and equivalents against 6.77B in total debt, resulting in a net debt position of 2.65B. Total book value stands at 2.81B, with working capital of -237.51M providing operational flexibility.

These figures cover the twelve months ended June 30, 2025.

Over the twelve months ended June 30, 2025, Ramsay Health Care Limited posted a gross margin of 77.34, reflecting its pricing power and cost economics. The operating margin of 4.93 and net profit margin of 0.14 provide insight into operational efficiency.

Over the twelve months ended June 30, 2025, Ramsay Health Care Limited paid dividends of 0.46 per share. The dividend payout ratio of 277.99 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 7.41, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Ramsay Health Care Limited shareholders.

Ramsay Health Care Limited's most recent stock split took place on April 19, 2005.

As of June 30, 2025, Ramsay Health Care Limited has an Altman Z-Score of 1.76, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.